Clinical pharmacology in drug development
Pharmacokinetics and Bioequivalence of two Empagliflozin Tablet Formulations: Results From a Randomized, Open-Label, Crossover Study in Fasting Healthy Volunteers.
Kar Ming Yee, Elton Sagim, Chuei Wuei Leong, Ivan Liew, Muhammad Najib Mahathar, Nurul Anis Zulhuda, Shahnun Ahmad, Nida Asnida Baharin, Narender Miryala, Narender Gaddamedi, Viresh Kumar Yarramshetti
Published: 202510.1002/cpdd.1614
Abstract
This study aimed to assess the bioequivalence of a newly developed generic formulation of empagliflozin in comparison with the reference product. A total of 32 healthy adult volunteers participated in an open-label, randomized, balanced, two-treatmen…
Preview only. Read the full abstract at the source